Timing of Toxicities and Non-relapse Mortality Following CAR T Therapy in Myeloma.
Wesson W, Dima D, Suleman N, Saif MSI, Tabak C, Logan E, Davis JA, McGann M, Furqan F, Mohan M, Rashid A, Abdallah AO, Ullah F, Shune L, Mushtaq MU, Raza S, McGuirk J, Hamadani M, Anwer F, Hashmi H, Ahmed N.
Wesson W, et al. Among authors: abdallah ao.
Transplant Cell Ther. 2024 Jun 11:S2666-6367(24)00469-X. doi: 10.1016/j.jtct.2024.06.012. Online ahead of print.
Transplant Cell Ther. 2024.
PMID: 38871056